-
Je něco špatně v tomto záznamu ?
Association between FTO polymorphism and COVID-19 mortality among older adults: A population-based cohort study
JA. Hubacek, N. Capkova, M. Bobak, H. Pikhart
Jazyk angličtina Země Kanada
Typ dokumentu časopisecké články
Grantová podpora
Wellcome Trust - United Kingdom
R01 AG023522
NIA NIH HHS - United States
NLK
Directory of Open Access Journals
od 1996
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-07-01
Open Access Digital Library
od 1996-01-01
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- alely MeSH
- COVID-19 * mortalita genetika virologie MeSH
- gen pro FTO * genetika MeSH
- genetická predispozice k nemoci MeSH
- jednonukleotidový polymorfismus * MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- SARS-CoV-2 fyziologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: COVID-19 caused a global pandemic with millions of deaths. Fat mass and obesity-associated gene (FTO) (alias m6A RNA demethylase) and its functional rs17817449 polymorphism are candidates to influence COVID-19-associated mortality since methylation status of viral nucleic acids is an important factor influencing viral viability. METHODS: We tested a population-based cohort of 5233 subjects (aged 63-87 years in 2020) where 70 persons died from COVID-19 and 394 from other causes during the pandemic period. RESULTS: The frequency of GG homozygotes was higher among those who died from COVID-19 (34%) than among survivors (19%) or deaths from other causes (20%), P <0.005. After multiple adjustments, GG homozygotes had a higher risk of death from COVID-19 with odds ratio = 2.01 (95% confidence interval; 1.19-3.41, P <0.01) compared with carriers of at least one T allele. The FTO polymorphism was not associated with mortality from other causes. CONCLUSIONS: Our results suggest that FTO variability is a significant predictor of COVID-19-associated mortality in Caucasians.
Charles University 3rd Department of Internal Medicine 1st Faculty of Medicine Prague Czech Republic
Institute of Clinical and Experimental Medicine Experimental Medicine Centre Prague Czech Republic
Masaryk University RECETOX Faculty of Science Brno Czech Republic
National Institute of Public Health Prague Czech Republic
University College London Institute of Epidemiology and Health Care London United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003669
- 003
- CZ-PrNML
- 005
- 20250206104611.0
- 007
- ta
- 008
- 250121e20240906xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijid.2024.107232 $2 doi
- 035 __
- $a (PubMed)39244150
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Hubacek, Jaroslav A $u Institute of Clinical and Experimental Medicine, Experimental Medicine Centre, Prague, Czech Republic; Charles University, Third Department of Internal Medicine, First Faculty of Medicine, Prague, Czech Republic. Electronic address: jahb@ikem.cz
- 245 10
- $a Association between FTO polymorphism and COVID-19 mortality among older adults: A population-based cohort study / $c JA. Hubacek, N. Capkova, M. Bobak, H. Pikhart
- 520 9_
- $a OBJECTIVES: COVID-19 caused a global pandemic with millions of deaths. Fat mass and obesity-associated gene (FTO) (alias m6A RNA demethylase) and its functional rs17817449 polymorphism are candidates to influence COVID-19-associated mortality since methylation status of viral nucleic acids is an important factor influencing viral viability. METHODS: We tested a population-based cohort of 5233 subjects (aged 63-87 years in 2020) where 70 persons died from COVID-19 and 394 from other causes during the pandemic period. RESULTS: The frequency of GG homozygotes was higher among those who died from COVID-19 (34%) than among survivors (19%) or deaths from other causes (20%), P <0.005. After multiple adjustments, GG homozygotes had a higher risk of death from COVID-19 with odds ratio = 2.01 (95% confidence interval; 1.19-3.41, P <0.01) compared with carriers of at least one T allele. The FTO polymorphism was not associated with mortality from other causes. CONCLUSIONS: Our results suggest that FTO variability is a significant predictor of COVID-19-associated mortality in Caucasians.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a alely $7 D000483
- 650 12
- $a gen pro FTO $x genetika $7 D000071516
- 650 _2
- $a kohortové studie $7 D015331
- 650 12
- $a COVID-19 $x mortalita $x genetika $x virologie $7 D000086382
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 12
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a SARS-CoV-2 $x fyziologie $7 D000086402
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Capkova, Nadezda $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a Bobak, Martin $u University College London, Institute of Epidemiology and Health Care, London, United Kingdom; Masaryk University, RECETOX, Faculty of Science, Brno, Czech Republic
- 700 1_
- $a Pikhart, Hynek $u University College London, Institute of Epidemiology and Health Care, London, United Kingdom; Masaryk University, RECETOX, Faculty of Science, Brno, Czech Republic
- 773 0_
- $w MED00005677 $t International journal of infectious diseases $x 1878-3511 $g Roč. 148 (20240906), s. 107232
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39244150 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104606 $b ABA008
- 999 __
- $a ok $b bmc $g 2263431 $s 1239676
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 148 $c - $d 107232 $e 20240906 $i 1878-3511 $m International journal of infectious diseases $n Int J Infect Dis $x MED00005677
- GRA __
- $p Wellcome Trust $2 United Kingdom
- GRA __
- $a R01 AG023522 $p NIA NIH HHS $2 United States
- LZP __
- $a Pubmed-20250121